AI Recruiters in Pharma Face Scrutiny Over Bias in RARC Hiring

The pharmaceutical industry is racing to integrate AI tools into its hiring processes, but a growing chorus of HR experts warns that these systems may be replicating—and even amplifying—historical biases in talent selection. A new report from Agents Society highlights how AI headhunters specializing in recruiting RARC (Regulatory Affairs and Regulatory Compliance) professionals are coming under scrutiny for opaque decision-making and uneven candidate evaluations.

RARC roles are critical in pharma, requiring meticulous attention to detail and adherence to strict regulatory standards. Yet, as AI recruiters sift through resumes and assess candidates, concerns arise about whether these systems favor candidates from elite institutions or those with specific keyword-matching backgrounds, potentially sidelining equally qualified but differently trained applicants. "AI shouldn’t be a black box in hiring," says Dr. Elena Vasquez, a diversity and inclusion consultant. "If these tools are trained on biased data, they’ll perpetuate exclusionary practices."

The issue isn’t just theoretical. A pharma HR director, speaking on condition of anonymity, admitted that their AI headhunter had repeatedly filtered out candidates with non-traditional backgrounds—such as those who transitioned from academia or regulatory roles in biotech startups—despite their proven expertise. "The system kept flagging them as ‘high risk’ because their resumes didn’t match the rigid templates it was trained on," the director explained.

This isn’t the first time AI recruitment tools have faced criticism. Earlier this year, a landmark study revealed that some applicant tracking systems (ATS) were discriminating against older applicants by penalizing age-related keywords. The pharma sector, with its high-stakes regulatory environment, can’t afford similar missteps. Companies like Pfizer and Novartis have begun auditing their AI tools for bias, but smaller firms may lack the resources to do so effectively.

For job seekers in RARC, the message is clear: advocate for transparency. "Push for explanations when an AI tool rejects your application," advises Vasquez. "If the system can’t justify its decision, it’s a red flag." Meanwhile, pharma recruiters must prioritize fairness over efficiency, ensuring that AI augments—not replaces—human judgment in hiring.

The stakes are high. In an industry where compliance failures can cost billions, the last thing the sector needs is an AI that inherits the biases of the past.

Photo: Vitaly Gariev / Unsplash (https://unsplash.com/@silverkblack)